1-13 of 13
Hong Ma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Armored Multivalent CAR-T Cells Targeting BCMA, GPRC5D, and CD38 Eradicate Antigen-Heterogeneous Multiple Myeloma, Address Antigen Escape and Enhance Expansion

Jincai Zhou, Xinran Luo, Bixia Lei, Kai Wu, Feifei Shi, Yuting Zhang, Jingyi Yu, Hong Ma, Zhe (Joy) Zhou, Xiaowen He
Journal: Blood
Blood (2024) 144 (Supplement 1): 2038.
https://doi.org/10.1182/blood-2024-207026
Published: 2024
Journal Articles

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Siguo Hao, MD PhD, Jie Jin, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Wenhao Zhang, MD PhD, Min Yang, MD PhD, Kang Yu, MD, Wei Wang, MDPhD, Linjun Chen, MD PhD, Haitao Meng, MD PhD, Mingxia He, MD, Jun Xiao, MD, Rong Tao, MD PhD, Xin Huang, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Jianbo Wan, MD PhD, Shasha Wang, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-140156
Published: 2020
Journal Articles

Results from Lummicar-2: A Phase 1b/2 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Patients with Relapsed and/or Refractory Multiple Myeloma

Shaji K. Kumar, MD, Rachid C. Baz, MD, Robert Z. Orlowski, MDPhD, Larry D. Anderson, Jr., MD PhD, Hong Ma, MD, Alexandria Shrewsbury, MS, Katrina A. Croghan, M.S., Mrinalini Bilgi, MS, Ankit Kansagra, MD, Prashant Kapoor, MD, Zonghai Li, MD PhD, Jason Brayer, PhDMD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-139802
Published: 2020
Journal Articles

Results from Lummicar-1: A Phase 1 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma

Wenming Chen, MD PhD, Chengcheng Fu, MD PhD, Zhen Cai, MD PhD, Zonghai Li, MD PhD, Huijuan Wang, MD PhD, Lingzhi Yan, MD PhD, Yin Wu, MD PhD, Xiaolan Shi, MD PhD, Wen Gao, MD, Shuang Yan, MD, Wei Wang, MDPhD, Xiaoyan Han, MD PhD, Gaofeng Zheng, MD PhD, Yanling Wen, MD, Jun Xiao, MD, Huamao Wang, PhD, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-140727
Published: 2020
Journal Articles

Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma

Jin Jie, MD PhD, Siguo Hao, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Min Yang, MD PhD, Wenhao Zhang, MD PhD, Kang Yu, MD, Jun Xiao, MD, Haitao Meng, MD PhD, Liyuan Ma, MD PhD, Mingxia He, MD, Wei WANG, MD PhD, Xin Huang, MD PhD, Linjun Chen, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Shasha Wang, MD PhD, Rong Tao, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4435.
https://doi.org/10.1182/blood-2019-126104
Published: 2019
Journal Articles

Targeting Human B-Precursor Acute Lymphoblastic Leukemia Cells with Recombinant Human CD19 Ligand

Fatih M. Uckun, MD, PhD, Lei Sun, PhD, Hong Ma, Ph.D., Sanjive Qazi, Ph.D., Ilker Dibirdik, Ph.D., Zahide Ozer, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 599.
https://doi.org/10.1182/blood.V116.21.599.599
Published: 2010
Journal Articles

Intronic CD22 Gene Mutations as A Pathogenic Mechanism of Human B-Precursor Leukemia

Fatih M. Uckun, MD, PhD, Patricia Goodman, Ph.D., Hong Ma, Ph.D., Ilker Dibirdik, Ph.D., Sanjive Qazi, Ph.D.
Journal: Blood
Blood (2010) 116 (21): 149.
https://doi.org/10.1182/blood.V116.21.149.149
Published: 2010
Journal Articles

The Gamma Catenin/CBP Complex Maintains Survivin Transcription In β-Catenin Deficient/Depleted Cancer Cells.

Yong-Mi Kim, MD, MPH, PhD, Hong Ma, Ph.D., Vivian Oehler, MD, Enzi Jiang, MD, PhD, Cu Nguyen, David P. Masiello, MD, Han Liu, Yi Zhao, MD, PhD, Jerald P. Radich, MD, Michael Kahn
Journal: Blood
Blood (2010) 116 (21): 1218.
https://doi.org/10.1182/blood.V116.21.1218.1218
Published: 2010
Journal Articles

Role of Survivin in Drug Resistant B-Cell Acute Lymphoblastic Leukemia.

Eugene Park, Enzi Jiang, MD, PhD, Gregor von Levetzow, Cihangir Duy, Lars Klemm, Yao-Te Hsieh, Asha Kadavallore, Hong Ma, PhD, Yi Zhao, MD, Cu Nguyen, John Groffen, PhD, Nora Heisterkamp, PhD, Markus Muschen, MD, Michael Kahn, PhD, Yong-Mi Kim, MD
Journal: Blood
Blood (2009) 114 (22): 10.
https://doi.org/10.1182/blood.V114.22.10.10
Published: 2009
Journal Articles

ITK-SYK Induces T-Cell Lymphoma with Accompanying Inflammatory Disease in Mice.

Christine Dierks, MD, Hong Ma, Hendrik Veelken, Markus Warmuth, MD, Francisco Adrian, PhD
Journal: Blood
Blood (2007) 110 (11): 693.
https://doi.org/10.1182/blood.V110.11.693.693
Published: 2007
Journal Articles

Angiogenic effects of prostaglandin E 2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells

Rosalba Salcedo, Xia Zhang, Howard A. Young, Nelson Michael, Ken Wasserman, Wei-Hong Ma, Manuela Martins-Green, William J. Murphy, Joost J. Oppenheim
Journal: Blood
Blood (2003) 102 (6): 1966–1977.
https://doi.org/10.1182/blood-2002-11-3400
Published: 2003
Journal Articles

High-level expression of hemoglobin A in human thalassemic erythroid progenitor cells following lentiviral vector delivery of an antisense snRNA

Marla M. Vacek, Hong Ma, Federica Gemignani, Giuseppina Lacerra, Tal Kafri, Ryszard Kole
Journal: Blood
Blood (2003) 101 (1): 104–111.
https://doi.org/10.1182/blood-2002-06-1869
Published: 2003
Journal Articles

Characterization of Epstein-Barr virus–infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response

Clinical Trials & Observations
Jie Yang, Qian Tao, Ian W. Flinn, Paul G. Murray, Linda E. Post, Hong Ma, Steven Piantadosi, Michael A. Caligiuri, Richard F. Ambinder
Journal: Blood
Blood (2000) 96 (13): 4055–4063.
https://doi.org/10.1182/blood.V96.13.4055
Published: 2000